×
For best experience we recommend to activate Javascript in your browser.
NOD1 antibody (AA 612-826)
The Rabbit Polyclonal anti-NOD1 antibody has been validated for WB, ELISA and IHC. It is suitable to detect NOD1 in samples from Human.
Quick Overview for NOD1 antibody (AA 612-826) (ABIN7570587)
Target
See all NOD1 Antibodies
NOD1
(Nucleotide-Binding Oligomerization Domain Containing 1 (NOD1))
Reactivity
All reactivities for NOD1 antibodies
Human
Host
All hosts for NOD1 antibodies
Rabbit
Clonality
All clonalities for NOD1 antibodies
Polyclonal
Conjugate
All conjugates for NOD1 antibodies
This NOD1 antibody is un-conjugated
Application
All applications for NOD1 antibodies
Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
Product Details anti-NOD1 Antibody
(hide)
Binding Specificity
All epitopes for NOD1 antibodies
AA 612-826
Purpose
Anti-NOD1 Polyclonal antibody
Purification
Antigen affinity purification.
Immunogen
E. coli - derived recombinant Human NOD1 (Ala612-Asp826).
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
0.01M PBS, pH 7.4, 50 % glycerol, 0.05 % Proclin 300.
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C,-80 °C
Storage Comment
Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt.
Target Details for NOD1
(hide)
Target
NOD1
(Nucleotide-Binding Oligomerization Domain Containing 1 (NOD1))
Alternative Name
NOD1
Background
NOD1,Nucleotide-binding oligomerization domain-containing protein 1,Caspase recruitment domain-containing protein 4,CARD4,
UniProt
Q9Y239
Pathways
Activation of Innate immune Response , Positive Regulation of Endopeptidase Activity , Toll-Like Receptors Cascades , Inflammasome
Recently viewed
(hide)
Chat with us , powered by LiveChat